Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Cardiovasc Res
    May 2026
  1. GARDEV A, Hausenloy DJ, Pekcec A
    Proteins targeting ischaemic-reperfusion injury and repair after myocardial infarction: a systematic literature review.
    Cardiovasc Res. 2026 May 7:cvag100. doi: 10.1093.
    >> Share

    April 2026
  2. PALA L, Torres-Lopez M, Caldwell ST, Valadares J, et al
    Mitochondrial succinate transport is required for cardiac ischaemia/reperfusion injury.
    Cardiovasc Res. 2026;122:734-747.
    >> Share

  3. GERGELY TG, Drobni ZD, Kovacs T, Sayour NV, et al
    Inhibition of the PD-1 immune checkpoint and the development of heart failure in the presence of prior cardiac ischemia.
    Cardiovasc Res. 2026 Apr 22:cvag085. doi: 10.1093.
    >> Share

  4. CLELAND JGF, Hurdus B, Gale CP
    Withholding beta-blockers after myocardial infarction: reasons to be cautious.
    Cardiovasc Res. 2026 Apr 2:cvag046. doi: 10.1093.
    >> Share

    March 2026
  5. ESPE EKS, Louch WE, Smith GL, Stokke MK, et al
    The border zone after myocardial infarction: clarification of terminology and proposal for a new definition.
    Cardiovasc Res. 2026;122:297-300.
    >> Share

  6. STEIN CS, Zhang X, Witmer NH, Pennington ER, et al
    Mitoregulin supports mitochondrial membrane integrity and protects against cardiac ischaemia-reperfusion injury.
    Cardiovasc Res. 2026;122:379-396.
    >> Share

  7. SUN X, Feng Y, Zhao Y, Cai Y, et al
    Maresin 1 ameliorates myocardial ischaemia?reperfusion injury by promoting tissue resident macrophage efferocytosis.
    Cardiovasc Res. 2026;122:397-411.
    >> Share

  8. MORALES-CANO D, Sharysh D, Albarran-Juarez J, de Molina A, et al
    Fibroblast-like cells accumulate late in human coronary atherosclerosis contributing to necrotic core formation.
    Cardiovasc Res. 2026;122:336-348.
    >> Share

  9. FURTADO M, Barbosa P, Wemans A, Zhang L, et al
    Shared splicing dysregulation in heart failure associated with dilated and ischemic cardiomyopathy and spatial specificity across cardiac regions.
    Cardiovasc Res. 2026 Mar 24:cvag068. doi: 10.1093.
    >> Share

  10. BAJAJ R, Huang X, Alves-Kotzev N, Weyers JJ, et al
    Deep learning-based plaque characterization in hybrid IVUS-OCT images is superior to single-modality deep learning analysis and human experts: head-to-head comparison against histology.
    Cardiovasc Res. 2026;122:245-257.
    >> Share

  11. KONDO Y, Koga JI, Orkhonselenge N, Wang L, et al
    Drp1-mediated mitochondrial fission protects macrophages from mtDNA/ZBP1-mediated inflammation and inhibits post-infarct cardiac remodelling.
    Cardiovasc Res. 2026;122:214-229.
    >> Share

  12. WANG T, Chen XZ, Xu HF, Wang JX, et al
    MCPPIR promotes cardiomyocyte proliferation and cardiac repair via o8G oxidation of POC1B mRNA.
    Cardiovasc Res. 2026;122:270-284.
    >> Share

    February 2026
  13. LEADER JH, Vilahur G, Ajjan RA, Kanji R, et al
    Relationship between body mass index and endogenous fibrinolytic status in 600 patients with ST-elevation myocardial infarction.
    Cardiovasc Res. 2026 Feb 27:cvag047. doi: 10.1093.
    >> Share

  14. FISCHER M, Sigle M, Manke MC, Marzi J, et al
    Platelet Casein Kinase 2alpha is a pivotal player in arterial thrombotic occlusion and post-ischemic myocardial remodeling.
    Cardiovasc Res. 2026;122:132-145.
    >> Share

  15. LI W, Zhou S, Liu J, Luo L, et al
    Identification of ALDH1A2-mediated cardioprotective benefits in myocardial ischaemia-reperfusion injury.
    Cardiovasc Res. 2026;121:2922-2938.
    >> Share

  16. GUO Z, Li L, Luo J, Xue W, et al
    The Ets2 super-enhancer modulates endothelial-mesenchymal transition during cardiac ageing.
    Cardiovasc Res. 2026;121:2892-2908.
    >> Share

    January 2026
  17. QUINTAVALLE C, Roscigno G, Petrillo G, Paolucci L, et al
    Proteomic profiling of extracellular vesicles in ST-elevation acute myocardial infarction.
    Cardiovasc Res. 2026 Jan 30:cvag033. doi: 10.1093.
    >> Share

  18. LI Y, Al Rimon R, Wang F, Li H, et al
    Temporal inhibition of ADAM17 in fibroblasts reduces stiffness and promotes vascularization following myocardial infarction.
    Cardiovasc Res. 2026 Jan 12:cvaf256. doi: 10.1093.
    >> Share

    December 2025
  19. ZHANG Y, Xiao T, Ding J, Jin H, et al
    Targeting olfactory receptor 2 on monocytes for cardioprotection against myocardial ischaemia-reperfusion injury via NR4A1-mediated mitochondrial fission.
    Cardiovasc Res. 2025;121:2759-2776.
    >> Share

    November 2025
  20. HE M, Tay WT, Song N, Liu T, et al
    Cardioprotective role of RBFox1 in myocardial infarction-induced heart failure.
    Cardiovasc Res. 2025 Nov 26:cvaf206. doi: 10.1093.
    >> Share

  21. CHEN Q, Liu J, Madonna R, Li F, et al
    Vasostatin-2 attenuates injury-induced neointimal hyperplasia through the ACE2/MasR/PPARgamma/NR1D1/Gas1 axis.
    Cardiovasc Res. 2025;121:2260-2277.
    >> Share

  22. TAYLOR DJ, Saxton H, Xu X, Yones E, et al
    Invasive validation of novel 1D models for computation of coronary fractional flow reserve.
    Cardiovasc Res. 2025;121:2233-2245.
    >> Share

  23. ZHANG Y, Dong Q, Bian X, Qiao Z, et al
    Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion.
    Cardiovasc Res. 2025 Nov 12:cvaf223. doi: 10.1093.
    >> Share

  24. BUGIARDINI R, Rahaman T, Manfrini O, Maas A, et al
    Diet and sex inequities in ischemic heart disease mortality across Europe: findings from the global burden of disease study.
    Cardiovasc Res. 2025 Nov 3:cvaf176. doi: 10.1093.
    >> Share

    October 2025
  25. NOONAN J, Prijaya SA, Bienvenu LA, Dayawansa NH, et al
    CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion.
    Cardiovasc Res. 2025 Oct 3:cvaf165. doi: 10.1093.
    >> Share

    September 2025
  26. GOLFOROUSH P, Sulaiman E, He D, Yellon DM, et al
    An activator of phosphatidylinositol 3-kinase alpha restores cardioprotection from ischaemia/reperfusion injury in mice with coronary atherosclerosis or insulin resistance.
    Cardiovasc Res. 2025;121:1722-1733.
    >> Share

  27. REILLY-O'DONNELL B, Ferraro E, Brody R, Tikhomirov R, et al
    Protective effect of ursodeoxycholic acid upon the post-myocardial infarction heart.
    Cardiovasc Res. 2025 Sep 12:cvaf133. doi: 10.1093.
    >> Share

    August 2025
  28. VOLPE M, Gallo G, Guzik TJ, Williams B, et al
    Blood pressure management in secondary prevention after myocardial infarction.
    Cardiovasc Res. 2025 Aug 26:cvaf145. doi: 10.1093.
    >> Share

  29. HADAYA J, Boukens BJD, Janse MJ, Cha S, et al
    Right stellate ganglion stimulation modulates arrhythmogenesis in acute left lateral ventricular ischaemia.
    Cardiovasc Res. 2025;121:1385-1391.
    >> Share

  30. GUTMANN C, Barwari T, Schulte C, Theofilatos K, et al
    Platelets and inflammation-insights from platelet non-coding RNA content and release in the Bruneck study and the PACMAN-AMI trial.
    Cardiovasc Res. 2025;121:1392-1406.
    >> Share

  31. STAPMANNS P, Abdelwahed YS, Wolfram C, Strassler E, et al
    Novel flow cytometry-based method for isolating and characterizing human coronary artery endothelial cells from catheter wires in coronary disease and microvascular dysfunction.
    Cardiovasc Res. 2025 Aug 9:cvaf139. doi: 10.1093.
    >> Share

    July 2025
  32. LARSSON I, Sun J, Ahmad S, Bergstrom G, et al
    Low-fibre diet is associated with high-risk coronary plaque features.
    Cardiovasc Res. 2025;121:1204-1214.
    >> Share

  33. ABALLO TJ, Bae J, Paltzer WG, Chapman EA, et al
    Integrated proteomics identifies troponin I isoform switch as a regulator of a sarcomere-metabolism axis during cardiac regeneration.
    Cardiovasc Res. 2025;121:1240-1253.
    >> Share

    June 2025
  34. NGUYEN TQ, Vlasenko D, Shetty AN, Zhao E, et al
    Systematic review and meta-analysis of respiratory viral triggers for acute myocardial infarction and stroke.
    Cardiovasc Res. 2025 Jun 17:cvaf092. doi: 10.1093.
    >> Share

  35. MYLONAS N, Siokatas G, Zacharia E, Pol C, et al
    Cardiac ischaemia/reperfusion in pigs and mice increases cardiomyocyte Kruppel-like factor 5 that aggravates tissue injury and remodelling.
    Cardiovasc Res. 2025;121:900-914.
    >> Share

  36. ZHANG S, Xiang B, Zhao Y, Wang W, et al
    Single-cell epigenomic and transcriptomic analysis unveils the pivotal role of GATA5/ISL1+ fibroblasts in cardiac repair post-myocardial infarction.
    Cardiovasc Res. 2025 Jun 3:cvaf101. doi: 10.1093.
    >> Share

    May 2025
  37. CHEN Q, Yu Y, Tong L, Weiss RM, et al
    Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling.
    Cardiovasc Res. 2025;121:760-774.
    >> Share

  38. TALABIEKE S, Yang X, Yang J, Wan Q, et al
    Arachidonic acid synergizes with aspirin preventing myocardial ischaemia-reperfusion injury and mitigates bleeding risk.
    Cardiovasc Res. 2025;121:775-787.
    >> Share

    April 2025
  39. AHMAD H, Gopakumar J, Nachun DC, Ma L, et al
    Single cell RNA sequencing of haematopoietic cells in fresh and frozen human atheroma tissue.
    Cardiovasc Res. 2025;121:396-404.
    >> Share

  40. BONACINA F, Carnevale D
    Sleep protects the heart after myocardial infarction through a neuro-immune axis: time to implement healthy sleep for cardiovascular prevention?
    Cardiovasc Res. 2025 Apr 23:cvaf073. doi: 10.1093.
    >> Share

  41. DARWESH AM, Fang L, Altamimi TR, Jamieson KL, et al
    Cardioprotective effect of 19,20-epoxydocosapentaenoic acid (19,20-EDP) in ischaemic injury involves direct activation of mitochondrial sirtuin 3.
    Cardiovasc Res. 2025;121:267-282.
    >> Share

  42. ZHANG W, Zhang Y, Han L, Bo T, et al
    Double-stranded DNA enhances platelet activation, thrombosis, and myocardial injury via cyclic GMP-AMP synthase.
    Cardiovasc Res. 2025;121:353-366.
    >> Share

  43. ROSLAN A, Paulus K, Yang J, Matt L, et al
    Slack K+ channels confer protection against myocardial ischaemia/reperfusion injury.
    Cardiovasc Res. 2025;121:174-189.
    >> Share

  44. DALKARA T, Ostergaard L, Heusch G, Attwell D, et al
    Pericytes in the brain and heart: functional roles and response to ischaemia and reperfusion.
    Cardiovasc Res. 2025;120:2336-2348.
    >> Share

    February 2025
  45. CHEN M, Zhao N, Shi W, Xing Y, et al
    Glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist tirzepatide promotes branched chain amino acid catabolism to prevent myocardial infarction in non-diabetic mice.
    Cardiovasc Res. 2025 Feb 10:cvaf005. doi: 10.1093.
    >> Share

  46. SHANG R, Rodrigues B
    Cardioprotective effects of a 'twincretin' drug tirzepatide in heart failure following myocardial infarction.
    Cardiovasc Res. 2025 Feb 4:cvaf006. doi: 10.1093.
    >> Share

    January 2025
  47. VILAHUR G, Ben-Aicha S, Gutierrez M, Radike M, et al
    Cardioprotection exerted by intravenous statin at index myocardial infarction event attenuates cardiac damage upon recurrent infarction.
    Cardiovasc Res. 2025 Jan 3:cvae264. doi: 10.1093.
    >> Share

    December 2024
  48. FABIN N, Cenko E, Bergami M, Yoon J, et al
    Early coronary revascularization among 'stable' patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age.
    Cardiovasc Res. 2024;120:2064-2077.
    >> Share

  49. TANG XL, Wysoczynski M, Gumpert AM, Solanki M, et al
    Intravenous infusions of mesenchymal stromal cells have cumulative beneficial effects in a porcine model of chronic ischaemic cardiomyopathy.
    Cardiovasc Res. 2024;120:1939-1952.
    >> Share

  50. TAN J, Min J, Jiang Y, Liu S, et al
    CircCHSY1 protects hearts against ischaemia/reperfusion injury by enhancing heme oxygenase 1 expression via miR-24-3p.
    Cardiovasc Res. 2024;120:1924-1938.
    >> Share

    November 2024
  51. AHERRAHROU R, Reinberger T, Hashmi S, Erdmann J, et al
    GWAS breakthroughs: mapping the journey from one locus to 393 significant coronary artery disease associations.
    Cardiovasc Res. 2024;120:1508-1530.
    >> Share

  52. PAN Z, Lv J, Zhao L, Xing K, et al
    CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages.
    Cardiovasc Res. 2024;120:1531-1549.
    >> Share

  53. ZHANG LJ, Hu YX, Huang RZ, Xu YY, et al
    Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition.
    Cardiovasc Res. 2024;120:1622-1635.
    >> Share

    October 2024
  54. WANG YJ, Matter CM
    Histone deacetylase 6 suppression protects from myocardial ischaemia-reperfusion injury in diabetes: insights from genetic deletion and pharmacological inhibition.
    Cardiovasc Res. 2024;120:1369-1371.
    >> Share

  55. BAUMGARDT SL, Fang J, Fu X, Liu Y, et al
    Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.
    Cardiovasc Res. 2024;120:1456-1471.
    >> Share

    September 2024
  56. YANG R, Ruan B, Wang R, Zhang X, et al
    Cardiomyocyte betaII spectrin plays a critical role in maintaining cardiac function by regulating mitochondrial respiratory function.
    Cardiovasc Res. 2024;120:1312-1326.
    >> Share

  57. HEIANZA Y, Wang X, Kou M, Tiwari S, et al
    Circulating dimethylguanidino valeric acid, dietary factors, and risk of coronary heart disease.
    Cardiovasc Res. 2024 Sep 7:cvae199. doi: 10.1093.
    >> Share

    August 2024
  58. PSALTIS PJ, Nguyen MT, Singh K, Sinhal A, et al
    Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction.
    Cardiovasc Res. 2024 Aug 27:cvae191. doi: 10.1093.
    >> Share

  59. VAN OORTMERSSEN JAE, Ntlapo N, Tilly MJ, Bramer WM, et al
    Burden of risk factors in women and men with unrecognised myocardial infarction: a systematic review and meta-analysis.
    Cardiovasc Res. 2024 Aug 27:cvae188. doi: 10.1093.
    >> Share

    July 2024
  60. HU M, Zhang X, Hu C, Ma ZG, et al
    Isthmin-1 alleviates cardiac ischaemia/reperfusion injury through cGMP-PKG signalling pathway.
    Cardiovasc Res. 2024;120:1051-1064.
    >> Share

  61. KUFAZVINEI TTJ, Chai J, Boden KA, Channon KM, et al
    Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes.
    Cardiovasc Res. 2024 Jul 19:cvae142. doi: 10.1093.
    >> Share

  62. COLEMAN JA, Doste R, Ashkir Z, Coppini R, et al
    Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.
    Cardiovasc Res. 2024;120:914-926.
    >> Share

  63. FU L, Du J, Furkert D, Shipton ML, et al
    Depleting inositol pyrophosphate 5-InsP7 protected the heart against ischaemia-reperfusion injury by elevating plasma adiponectin.
    Cardiovasc Res. 2024;120:954-970.
    >> Share

    June 2024
  64. PHAM QH, Bui TVA, Sim WS, Lim KH, et al
    Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischemic heart disease.
    Cardiovasc Res. 2024 Jun 8:cvae128. doi: 10.1093.
    >> Share

  65. GRECO CM, Nisoli E
    The ketogenic diet is unable to improve cardiac function in ischemic heart failure: an unexpected result?
    Cardiovasc Res. 2024 Jun 6:cvae126. doi: 10.1093.
    >> Share

    May 2024
  66. SUGIYAMA T, Jang IK
    Is cutting-edge imaging technology superior to conventional angiography in improving outcomes of coronary artery stenting?
    Cardiovasc Res. 2024;120:e17-e19.
    >> Share

  67. HO KL, Karwi Q, Wang F, Wagg C, et al
    The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischemic heart failure.
    Cardiovasc Res. 2024 May 1:cvae092. doi: 10.1093.
    >> Share

    April 2024
  68. MEHDIZADEH M, Naud P, Abu-Taha IH, Hiram R, et al
    The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology.
    Cardiovasc Res. 2024;120:506-518.
    >> Share

  69. SUN Q, Chen W, Wu R, Tao B, et al
    Serine protease inhibitor, SerpinA3n regulates cardiac remodeling after myocardial infarction.
    Cardiovasc Res. 2024 Apr 26:cvae075. doi: 10.1093.
    >> Share

    February 2024
  70. KIZER JR
    The elusive quest for causality in adiponectin's bimodal relationship with cardiovascular disease: Mendelian randomization meets Janus.
    Cardiovasc Res. 2024;120:3-5.
    >> Share

  71. DE WIT S, Geerlings L, Shi C, Dronkers J, et al
    Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice.
    Cardiovasc Res. 2024 Feb 24:cvae038. doi: 10.1093.
    >> Share

  72. TORIMOTO K, Elliott K, Nakayama Y, Yanagisawa H, et al
    Cardiac and perivascular myofibroblasts, matrifibrocytes, and immune fibrocytes in hypertension; commonalities and differences with myocardial infarction and other cardiovascular diseases.
    Cardiovasc Res. 2024 Feb 23:cvae044. doi: 10.1093.
    >> Share

    January 2024
  73. ABOULEISA RRE, Tang XL, Ou Q, Salama AM, et al
    Gene therapy encoding cell cycle factors to treat chronic ischemic heart failure in rats.
    Cardiovasc Res. 2024 Jan 4:cvae002. doi: 10.1093.
    >> Share

    December 2023
  74. HIRAM R, Xiong F, Naud P, Xiao J, et al
    An inflammation resolution-promoting intervention prevents atrial fibrillation due to left-ventricular dysfunction.
    Cardiovasc Res. 2023 Dec 13:cvad175. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016